Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FOC U024 - From Bench to Bedside: Important Clinical Advances

Ticket required for admission, no tuition fee. Ticket holds seat for only 15 minutes after the official start time.


Date: Saturday, August 18

CME Credits: 1.50

Location: Room 204

Time: 8:00 AM - 9:30 AM

Director: Oscar Colegio, MD, PhD, FAAD

Learning Objectives:
Following this course, the attendee should be able to:

  • Describe molecular pathways recently discovered to be effective targets for treating melanoma, basal cell carcinoma and dermatofibrosarcoma protuberans.
  • Summarize the efficacy of recently approved therapies or therapies currently in trials for the treatment of skin cancers.

Systemic and topical molecularly targeted therapies are emerging as a rational approach to the management of skin cancers. In this session, the rationale behind and effectiveness of new molecules used in the treatment of melanoma, basal cell carcinoma, dermatofibrosarcoma protuberans and Kaposi’s sarcoma will be reviewed. This session is designed for a broad audience, from practicing dermatologists to basic scientists.